BORDOLOI BIOTECH

Bordoloi Biotech (BB) was founded in 2012 by Dr. B. K. Bordoloi after over 20 years of experience in the Medical Device and Pharmaceutical industries. These included exposures at leading US corporations including Johnson & Johnson and Baxter Healthcare Corp. The mission of BB is to carry out research and develop focused chemistry solutions of unmet needs in biological systems in the areas of inflammation, pain, and tissue engineering. Deliverables of Bordoloi Biotech include technology, intellectual property, new product and business development... Bordoloi Biotech has developed technology solutions for improving longevity of fibrin clot or sealant for wound healing in hemostasis and tissue regeneration in surgical applications, with US patents granted in this area. BB is seeking opportunities for licensing out patents to interested companies for developing new products with competitive advantage in regenerative medicine and tissue engineering.

Also known as: Bordoloi Biotech India Pvt. Ltd., Bordoloi Biotech, LLC

Primary location: United States